Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-McDonald's, Crocs, Amicus, Urban Outfitters, Pep Boys

Tue, 10th Sep 2013 13:16

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday:

FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS

U.S. stock index futures rose, putting the S&P 500 on trackfor a sixth day of gains, following another batch of rosyeconomic data out of China and as expectations eased about aWestern military strike against Syria. S&P 500 futures rose 10.4 points, Dow Jones industrial average futures gained 88 points, and Nasdaq 100 futures added 21points.

** APPLE INC, Monday close $506.17, up 0.5 pctpremarket

Apple is expected to introduce a cheaper version of theiPhone on Tuesday, bringing one of the industry's costliestsmartphones within reach of the masses in poorer emergingmarkets.

** MCDONALD'S CORP, Monday close $96.45, up 1 pctpremarket

The fast food chain reported a better-than-expected 1.9percent increase in global sales at established restaurants inAugust, helped by stronger sales in Europe.

** GOLDMAN SACHS GROUP INC, Monday close $159.49, up2.7 pct premarket

** VISA INC, Monday close $178.55, up 2.5 pctpremarket

** NIKE INC, Monday close $65.40, up 2.3 pctpremarket

** ALCOA INC, Monday close $8.08, down 1.2 pctpremarket

** BANK OF AMERICA CORP, Monday close $14.48

** HEWLETT-PACKARD CO, Monday close $22.36, down 1.3pct premarket

Goldman Sachs, Visa and Nike will replace Alcoa,Bank of America and Hewlett-Packard as components of the DowJones Industrial Average, effective Sept. 23.

** AMICUS THERAPEUTICS, Monday close $2.55, up 20pct premarket

The biotechnology company said it has entered into acollaboration with Biogen Idec to develop andcommercialize novel small molecules for the treatment ofParkinson's disease. The collaboration includes funding byBiogen.

** CHEMOCENTRYX INC, Monday close $8.26, down 19pct premarket

The biopharmaceutical company said its experimental drug fortreating a diabetic kidney disease reduced the level of proteinin the urine, a sign of kidney damage. Interim data from amid-stage trial of the drug, CCX140, showed patients getting 5mg doses for two weeks had a 12 percent reduction in urineprotein levels.

Investment website SeekingAlpha.com said investors mighthave been expecting a reduction of 20 percent or more.

** URBAN OUTFITTERS INC, Monday close $42.71, down8 pct after market

The teen apparel chain said in a regulatory filing on Mondaythat percentage growth in its same-store net sales, includingonline sales, was trending in the mid-single digit in thecurrent quarter. This forecast missed analysts' estimates.Janney Capital Markets analyst Adrienne Tennant cut the pricetarget on the stock to $46 from $52, saying she expected the 9percent growth of the second quarter to continue into thisquarter.

** CYTORI THERAPEUTICS INC, Monday close $2.39, up7 pct premarket

Roth Capital Partners reinstated its "buy" rating on themedical device maker's stock with a $10 price target, sayingpositive data from the trials on Cytori's cell therapy forchronic ischemic heart failure would boost its U.S. profile.

** CROCS INC, Monday close $13.61, down 5 pctpremarket

The maker of colorful clogs cut its revenue and profitforecasts for the quarter ending Sept. 30, citing weakness inits Americas business.

** PEP BOYS-MANNY MOE AND JACK, Monday close $11.52,down 4 pct premarket

The auto repair chain reported a lower-than-expected profitfor the second quarter as tire sales fell.

** MODEL N INC, Monday close $14.73, down 38 pctpremarket

The revenue management software maker forecast revenue forthe year ending September 2014 below analysts' estimates onMonday. Raymond James, Stifel Nicolaus and JPMorgan cut their ratings on the stock on Tuesday.

Analysts at Stifel said the company did not clearlyarticulate a plan to cut expenses. Raymond James analysts said areturn to revenue growth could be delayed well into 2015 unlessthe company quickly improved sales execution.

** NEUROCRINE BIOSCIENCES INC, Monday close $16.70,down 28 pct premarket

The company said on Monday that a lower dose of itsexperimental drug to treat a rare movement disorder did not meetthe main goal of a mid-stage clinical study. Cowen and Co cut its price target on the stock to $19 from $20while MKM Partners cut its target to $13.50 from $17.00 andOppenheimer to $15 from $19.

** MARVELL TECHNOLOGY GROUP LTD, Monday close$12.57, up 3 pct premarket

J.P. Morgan Securities upgraded the chipmaker's stock to"overweight" from "neutral", saying the company's productdevelopment and execution over the last 18 months has spurredgrowth in its mobile/wireless and storage markets. Thebrokerage, expecting the company to control costs, raised itsprice target on the stock to $16 from $14.

** PALO ALTO NETWORKS INC, Monday close $46.84, up3.3 pct premarket

The security software maker on Monday reportedbetter-than-expected revenue for the fourth quarter, citing arise in demand for its appliances and contributions from morerecurring subscription and maintenance services. At least four brokerages raised their price targets on thestock.

** HD SUPPLY HOLDINGS INC, Monday close $24.74, down9.5 pct premarket

The construction products supplier reported a widerquarterly loss for the second quarter due to expenses associatedwith debt restructuring. The company also forecast fiscal 2013results below analysts' estimates.

** STARWOOD PROPERTY TRUST INC, Monday close$25.04, down 4 pct premarket

The company, which finances and manages commercial mortgageloans, said it was offering 25 million shares in an underwrittenpublic offering.

** L&L ENERGY INC, Monday close $2.89, up 15 pctafter market

The coal miner's first-quarter profit more than doubled asproduction was boosted by the acquisition of two mines in Chinain November. Production rose 54 percent to 228,000 tons in thequarter.

** FIVE BELOW INC, Monday close $41.04, up 14 pctafter market

The specialty value retailer reported better-than-expectedresults for the second quarter due to a 6.6 percent increase insame-store sales. The company also raised its full-year earningsand revenue forecast.

** PVH CORP, Monday close $132.11, down 4.4 pctafter market

The maker of Calvin Klein and Tommy Hilfiger clothes gave athird-quarter sales and profit forecast that was below analysts'estimates. The company characterized the global environment as"challenging".

** BLACKBERRY LTD, Monday close $11.53, down 4 pctpremarket

The Canadian company's biggest shareholder has approachedseveral large Canadian investment funds about forging a deal totake the smartphone maker private, but the proposal is still "anairy-fairy, 'what if' kind of thing," according to a source withdirect knowledge of the situation.

** GLAXOSMITHKLINE PLC, Monday close $50.46, down 1pct premarket

The threat of generic copies of the company's best-sellinglung drug Advair finally making it to the market in the UnitedStates hit confidence in the drugmaker.

** MICROSOFT CORP, Monday close $31.65, up 1 pctpremarket

At least three of the top 20 investors in the company want aturnaround expert to succeed Steve Ballmer as chief executive.They have urged the technology giant's board to consider FordMotor Co Chief Executive Alan Mulally and ComputerSciences Corp Chief Executive Mike Lawrie for the job,several sources familiar with the matter said.

** VODAFONE PLC , Monday close $33.34, down1.5 pct premarket

The company is facing pressure from Kabel Deutschland's largest shareholder to raise its 7.7 billion euro($10.1 billion) offer for Germany's largest cable company, twosources familiar with the situation told Reuters on Monday. Activist investor Paul E. Singer, founder of U.S. hedge fundElliott Asset Management, more than doubled his stake to 10.9percent on Sept. 6, Kabel Deutschland said on Monday two daysbefore shareholders have to decide whether to accept Vodafone'soffer.

** ADVANCED MICRO DEVICES INC, Monday close $3.69,up 2 pct premarket

The chipmaker, targeting new markets as personal computersales decline, unveiled chips designed to run slot machines,factory robots, airport signs, medical equipment and otherdevices. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.